AllRock Bio
Natick, US · 21 employees on LinkedIn · 3 known investors
Find your way into AllRock Bio
275 people in our graph share verified history with the AllRock Bio team — schools, employers, funds. One of them is your warm intro.
Stacey Barnesunlockedknows Catherine Pearce, DHSc, MBA · together at CincyTech (overlapped)
×10knows the team · via CincyTech
knows the team · via Xavier University
AllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions. Its lead program is an orally administered pan-ROCK inhibitor being investigated in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.
Founders & leadership
CP
D
DHScFounder
JR
Investors · 3
Competitors · 3
by search overlap
Scholar Rock17 shared keywordsScholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases. The company uses a selective protein targeting approach designed to inhibit disease mechanisms rather than manage their downstream effects.
Aro Biotherapeutics9 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Korro Bio8 shared keywordsKorro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.
Companies competing with AllRock Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does AllRock Bio do?
- AllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions. Its lead program is an orally administered pan-ROCK inhibitor being investigated in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.
- Who founded AllRock Bio?
- AllRock Bio was founded by Catherine Pearce, DHSc, Justin R Thompson.
- Who are AllRock Bio's investors?
- AllRock Bio's investors include Versant Ventures, Westlake BioPartners, Westlake Village BioPartners.
- Where is AllRock Bio headquartered?
- AllRock Bio is headquartered in Natick, US.